As of 4:02pm ET
| -0.19 / -0.18%|
The 20 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 130.50, with a high estimate of 155.00 and a low estimate of 111.00. The median estimate represents a +24.98% increase from the last price of 104.42.
The current consensus among 25 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.